Related Experiment Video
Updated: Aug 8, 2026
07:54
Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
Published on: August 19, 2014
Cancer progression by non-clonal chromosome aberrations
Henry H Q Heng1, Steven W Bremer, Joshua Stevens
1Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. hheng@med.wayne.edu
Journal of Cellular Biochemistry
|May 6, 2006
Summary
Cancer progression is driven by genomic instability and stochastic non-clonal chromosome aberrations (NCCAs), not just linear genetic changes. Understanding NCCA dynamics is key to solid tumor evolution and developing new cancer models.
Area of Science:
- Genomics
- Cancer Research
- Evolutionary Biology
Background:
- Current cancer models focus on stepwise genetic aberrations, influenced by hematologic cancer studies.
- This linear progression model is challenged by non-linear patterns and stochastic progression in most cancers.
- Genomic instability is now linked to stochastic non-clonal chromosome aberrations (NCCAs).
Purpose of the Study:
- To propose that the dynamics of NCCAs are crucial for karyotypic evolution in solid tumors.
- To reframe cancer progression as a dynamic interplay between NCCAs and clonal chromosome aberrations (CCAs).
- To explore the role of stochastic genomic variation in cancer development.
Main Methods:
- Reviewing basic elements of cancer initiation and progression within an evolutionary context.
- Analyzing karyotype patterns across various cancer types.
- Developing four cancer evolutionary models based on NCCA/CCA dynamics.
Main Results:
- Stochastic changes occur at gene, epigenetic, and chromosomal levels, with chromosomal/genomic levels being primary.
- NCCA-mediated genomic variation plays a dominant role in cancer progression.
- Four distinct cancer evolutionary models illustrating NCCA/CCA cycles were proposed.
Conclusions:
- Cancer progression, particularly in solid tumors, is significantly influenced by the dynamics of NCCAs.
- NCCA-mediated genomic variation is a key driver of karyotypic evolution.
- The proposed models offer a new framework for understanding cancer evolution beyond linear progression.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...